Shuttle Pharmaceuticals (SHPH) Competitors $0.28 +0.01 (+5.16%) Closing price 04:00 PM EasternExtended Trading$0.29 +0.01 (+2.06%) As of 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. NKGN, PTN, LIPO, BCLI, FRTX, GTBP, GNPX, ALBT, NLSP, and SNGXShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include NKGen Biotech (NKGN), Palatin Technologies (PTN), Lipella Pharmaceuticals (LIPO), Brainstorm Cell Therapeutics (BCLI), Fresh Tracks Therapeutics (FRTX), GT Biopharma (GTBP), Genprex (GNPX), Avalon GloboCare (ALBT), NLS Pharmaceutics (NLSP), and Soligenix (SNGX). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. NKGen Biotech Palatin Technologies Lipella Pharmaceuticals Brainstorm Cell Therapeutics Fresh Tracks Therapeutics GT Biopharma Genprex Avalon GloboCare NLS Pharmaceutics Soligenix Shuttle Pharmaceuticals (NASDAQ:SHPH) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Does the media favor SHPH or NKGN? In the previous week, Shuttle Pharmaceuticals had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for Shuttle Pharmaceuticals and 0 mentions for NKGen Biotech. Shuttle Pharmaceuticals' average media sentiment score of 0.43 beat NKGen Biotech's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Shuttle Pharmaceuticals Neutral NKGen Biotech Neutral Which has more volatility and risk, SHPH or NKGN? Shuttle Pharmaceuticals has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Which has stronger valuation & earnings, SHPH or NKGN? Shuttle Pharmaceuticals has higher earnings, but lower revenue than NKGen Biotech. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.07NKGen Biotech$80K74.95-$82.94M-$2.45-0.05 Does the MarketBeat Community believe in SHPH or NKGN? Shuttle Pharmaceuticals and NKGen Biotech both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformShuttle PharmaceuticalsN/AN/ANKGen BiotechN/AN/A Do institutionals & insiders hold more shares of SHPH or NKGN? 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 10.4% of NKGen Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is SHPH or NKGN more profitable? NKGen Biotech's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -583.02% -258.92% NKGen Biotech N/A N/A -479.36% SummaryNKGen Biotech beats Shuttle Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.76M$6.71B$5.49B$7.95BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.077.3522.6218.58Price / SalesN/A241.98397.85103.49Price / CashN/A65.8538.1834.62Price / Book0.146.496.744.25Net Income-$6.59M$143.41M$3.22B$248.18M7 Day Performance-5.19%2.24%1.59%1.36%1 Month Performance-31.03%7.16%4.09%3.85%1 Year PerformanceN/A-2.45%15.98%5.37% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.6283 of 5 stars$0.28+5.2%N/AN/A$1.76MN/A-0.075Gap UpNKGNNKGen BiotechN/A$0.14+5.9%N/A-89.1%$6.07M$80,000.00-0.03N/AGap DownPTNPalatin TechnologiesN/A$0.23+5.0%N/AN/A$6.01M$350,000.00-0.1530News CoverageGap DownLIPOLipella Pharmaceuticals2.4561 of 5 stars$2.28-5.0%N/A-57.3%$5.81M$536,357.00-0.544Upcoming EarningsBCLIBrainstorm Cell Therapeutics3.7009 of 5 stars$0.86-1.8%$30.00+3,388.4%-77.0%$5.71MN/A-0.1840Short Interest ↑Positive NewsGap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+2.7%$5.59M$10.06M-0.6620GTBPGT Biopharma3.5018 of 5 stars$2.17-4.4%$11.00+406.9%-19.3%$5.50MN/A-0.318Short Interest ↓Positive NewsGap DownGNPXGenprex4.0101 of 5 stars$0.23-6.2%$10.00+4,342.5%-87.2%$5.44MN/A0.0020News CoverageGap DownALBTAvalon GloboCare0.9525 of 5 stars$3.23-9.5%N/A-9.3%$5.34M$1.31M-0.165Short Interest ↑News CoverageGap UpNLSPNLS PharmaceuticsN/A$1.45-0.7%N/A+953.7%$5.22MN/A0.006SNGXSoligenix0.3113 of 5 stars$2.07-1.4%N/A-68.4%$5.20M$840,000.00-0.2720News Coverage Related Companies and Tools Related Companies NKGN Alternatives PTN Alternatives LIPO Alternatives BCLI Alternatives FRTX Alternatives GTBP Alternatives GNPX Alternatives ALBT Alternatives NLSP Alternatives SNGX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.